{"transactions":[{"id":728646,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35904,"kind":"person","name":"Lucidi Bruno","position":1,"cik":"0001829622","reported_name":"Lucidi Bruno","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:20.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279728/ownership.xml","form_type":"4"}},{"id":728645,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35904,"kind":"person","name":"Lucidi Bruno","position":1,"cik":"0001829622","reported_name":"Lucidi Bruno","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:20.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279728/ownership.xml","form_type":"4"}},{"id":728644,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35904,"kind":"person","name":"Lucidi Bruno","position":1,"cik":"0001829622","reported_name":"Lucidi Bruno","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:20.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001193125-26-279728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279728/ownership.xml","form_type":"4"}},{"id":728643,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35904,"kind":"person","name":"Lucidi Bruno","position":1,"cik":"0001829622","reported_name":"Lucidi Bruno","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:00:20.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":142350,"source":{"system":"sec-edgar","filing":"0001193125-26-279728","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279728/ownership.xml","form_type":"4"}},{"id":728790,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:17.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000119312526279726/ownership.xml","form_type":"4"}},{"id":728789,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:17.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000119312526279726/ownership.xml","form_type":"4"}},{"id":728788,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:17.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001193125-26-279726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000119312526279726/ownership.xml","form_type":"4"}},{"id":728787,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:00:17.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":536097,"source":{"system":"sec-edgar","filing":"0001193125-26-279726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000119312526279726/ownership.xml","form_type":"4"}},{"id":728642,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:12.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279723","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279723/ownership.xml","form_type":"4"}},{"id":728641,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:12.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279723","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279723/ownership.xml","form_type":"4"}},{"id":728819,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35951,"kind":"person","name":"DUNCAN BARBARA GAYLE","position":1,"cik":"0001353128","reported_name":"DUNCAN BARBARA GAYLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:09.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279721","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1353128/000119312526279721/ownership.xml","form_type":"4"}},{"id":728818,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35951,"kind":"person","name":"DUNCAN BARBARA GAYLE","position":1,"cik":"0001353128","reported_name":"DUNCAN BARBARA GAYLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:09.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279721","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1353128/000119312526279721/ownership.xml","form_type":"4"}},{"id":728817,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35951,"kind":"person","name":"DUNCAN BARBARA GAYLE","position":1,"cik":"0001353128","reported_name":"DUNCAN BARBARA GAYLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:09.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001193125-26-279721","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1353128/000119312526279721/ownership.xml","form_type":"4"}},{"id":728816,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35951,"kind":"person","name":"DUNCAN BARBARA GAYLE","position":1,"cik":"0001353128","reported_name":"DUNCAN BARBARA GAYLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:00:09.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":92350,"source":{"system":"sec-edgar","filing":"0001193125-26-279721","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1353128/000119312526279721/ownership.xml","form_type":"4"}},{"id":729120,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:08.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000119312526279719/ownership.xml","form_type":"4"}},{"id":729119,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:08.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000119312526279719/ownership.xml","form_type":"4"}},{"id":729118,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:08.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001193125-26-279719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000119312526279719/ownership.xml","form_type":"4"}},{"id":729117,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:00:08.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":124806,"source":{"system":"sec-edgar","filing":"0001193125-26-279719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000119312526279719/ownership.xml","form_type":"4"}},{"id":728640,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:06.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279718/ownership.xml","form_type":"4"}},{"id":728639,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:06.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279718/ownership.xml","form_type":"4"}},{"id":728638,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:06.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001193125-26-279718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279718/ownership.xml","form_type":"4"}},{"id":728637,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:00:06.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":121745,"source":{"system":"sec-edgar","filing":"0001193125-26-279718","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526279718/ownership.xml","form_type":"4"}},{"id":729267,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":36015,"kind":"person","name":"Adams Jerome M.","position":1,"cik":"0001863366","reported_name":"Adams Jerome M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:04.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863366/000119312526279720/ownership.xml","form_type":"4"}},{"id":729266,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":36015,"kind":"person","name":"Adams Jerome M.","position":1,"cik":"0001863366","reported_name":"Adams Jerome M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:04.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863366/000119312526279720/ownership.xml","form_type":"4"}},{"id":729265,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":36015,"kind":"person","name":"Adams Jerome M.","position":1,"cik":"0001863366","reported_name":"Adams Jerome M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:04.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in full on June 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001193125-26-279720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863366/000119312526279720/ownership.xml","form_type":"4"}},{"id":729264,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":36015,"kind":"person","name":"Adams Jerome M.","position":1,"cik":"0001863366","reported_name":"Adams Jerome M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T21:00:04.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":92350,"source":{"system":"sec-edgar","filing":"0001193125-26-279720","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863366/000119312526279720/ownership.xml","form_type":"4"}},{"id":728800,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":31472,"kind":"person","name":"KIRSCH ARTHUR S","position":1,"cik":"0001290976","reported_name":"KIRSCH ARTHUR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-23T21:00:03.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":37700,"derivative":{"exercise_price":4.36,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001193125-26-279717","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1290976/000119312526279717/ownership.xml","form_type":"4"}},{"id":728799,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":31472,"kind":"person","name":"KIRSCH ARTHUR S","position":1,"cik":"0001290976","reported_name":"KIRSCH ARTHUR S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-23T21:00:03.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":26700,"derivative":{"underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001193125-26-279717","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290976/000119312526279717/ownership.xml","form_type":"4"}},{"id":767485,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T22:30:02.000Z","date":"2026-05-18","kind":"purchase","planned":false,"acquired":true,"shares":6100,"price":4.1715,"value":25446.15,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4/A has been filed solely to correct the date of the transaction reported in Column 2 of Table I of the Reporting Person's Form 4 filed on May 20, 2026, which was inadvertently noted as \"May 18, 2025\" instead of \"May 18, 2026.\""},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":92145,"source":{"system":"sec-edgar","filing":"0001193125-26-235039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526235039/ownership.xml","form_type":"4/A","original_submission_date":"2026-05-20"}},{"id":769595,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T20:15:21.000Z","date":"2025-05-18","kind":"purchase","planned":false,"acquired":true,"shares":6100,"price":4.1715,"value":25446.15,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":92145,"source":{"system":"sec-edgar","filing":"0001193125-26-232612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526232612/ownership.xml","form_type":"4"}},{"id":843772,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-13T18:00:09.000Z","date":"2026-03-11","kind":"exercise","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.24,"expiration_date":"2026-12-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193125-26-106547","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526106547/ownership.xml","form_type":"4"}},{"id":843771,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-13T18:00:09.000Z","date":"2026-03-11","kind":"exercise","planned":false,"acquired":true,"shares":60000,"price":1.24,"value":74400.0,"ownership":{"direct":true},"balance_after":823576,"source":{"system":"sec-edgar","filing":"0001193125-26-106547","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526106547/ownership.xml","form_type":"4"}},{"id":921060,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67906,"kind":"person","name":"Horga Maria Arantxa","position":1,"cik":"0001829614","reported_name":"Horga Maria Arantxa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T00:53:00.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":173500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030."}],"balance_after":173500,"derivative":{"exercise_price":4.24,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":173500},"source":{"system":"sec-edgar","filing":"0001193125-26-036281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036281/ownership.xml","form_type":"4"}},{"id":921059,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67906,"kind":"person","name":"Horga Maria Arantxa","position":1,"cik":"0001829614","reported_name":"Horga Maria Arantxa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T00:53:00.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":9750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9750},"source":{"system":"sec-edgar","filing":"0001193125-26-036281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036281/ownership.xml","form_type":"4"}},{"id":921058,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67906,"kind":"person","name":"Horga Maria Arantxa","position":1,"cik":"0001829614","reported_name":"Horga Maria Arantxa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T00:53:00.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":41533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant of 124,600 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The original grant of 124,600 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":41533},"source":{"system":"sec-edgar","filing":"0001193125-26-036281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036281/ownership.xml","form_type":"4"}},{"id":921057,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67906,"kind":"person","name":"Horga Maria Arantxa","position":1,"cik":"0001829614","reported_name":"Horga Maria Arantxa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-04T00:53:00.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":16073,"price":4.24,"value":68149.52,"ownership":{"direct":true},"balance_after":96086,"source":{"system":"sec-edgar","filing":"0001193125-26-036281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036281/ownership.xml","form_type":"4"}},{"id":921056,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67906,"kind":"person","name":"Horga Maria Arantxa","position":1,"cik":"0001829614","reported_name":"Horga Maria Arantxa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-04T00:53:00.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":51283,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":112159,"source":{"system":"sec-edgar","filing":"0001193125-26-036281","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036281/ownership.xml","form_type":"4"}},{"id":921055,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T00:47:27.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":119520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030."}],"balance_after":119520,"derivative":{"exercise_price":4.24,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":119520},"source":{"system":"sec-edgar","filing":"0001193125-26-036272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036272/ownership.xml","form_type":"4"}},{"id":921054,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T00:47:27.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001193125-26-036272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036272/ownership.xml","form_type":"4"}},{"id":921053,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T00:47:27.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001193125-26-036272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036272/ownership.xml","form_type":"4"}},{"id":921052,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-04T00:47:27.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":11570,"price":4.24,"value":49056.8,"ownership":{"direct":true},"balance_after":82594,"source":{"system":"sec-edgar","filing":"0001193125-26-036272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036272/ownership.xml","form_type":"4"}},{"id":921051,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-04T00:47:27.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":42083,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":94164,"source":{"system":"sec-edgar","filing":"0001193125-26-036272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036272/ownership.xml","form_type":"4"}},{"id":921050,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":177000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030."}],"balance_after":177000,"derivative":{"exercise_price":4.24,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":177000},"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":921049,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":921048,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":46800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original grant of 140,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original grant of 140,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":46800},"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":921047,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14136,"price":4.24,"value":59936.64,"ownership":{"direct":true},"balance_after":127665,"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":921046,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-02-04T00:46:49.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":58050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,363 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan."}],"balance_after":141801,"source":{"system":"sec-edgar","filing":"0001193125-26-036270","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000119312526036270/ownership.xml","form_type":"4"}},{"id":921519,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030."}],"balance_after":180000,"derivative":{"exercise_price":4.24,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":921518,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":921517,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":44366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original grant of 133,100 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original grant of 133,100 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44366},"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":921516,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":16104,"price":4.24,"value":68280.96,"ownership":{"direct":true},"balance_after":763576,"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":921515,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":60960,"kind":"person","name":"Corcoran Andrea","position":1,"cik":"0001296996","reported_name":"Corcoran Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-03T19:46:35.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":54866,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,507 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan."}],"balance_after":779680,"source":{"system":"sec-edgar","filing":"0001193125-26-036269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296996/000119312526036269/ownership.xml","form_type":"4"}},{"id":921525,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67945,"kind":"person","name":"Sommadossi Jean-Pierre","position":1,"cik":"0001296995","reported_name":"Sommadossi Jean-Pierre","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, and Chairman"}}],"security":"Stock  Option  (Right to  Buy)","published_at":"2026-02-03T19:46:07.000Z","date":"2026-02-03","kind":"exercise","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.24,"expiration_date":"2026-12-08","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001193125-26-036268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1296995/000119312526036268/ownership.xml","form_type":"4"}},{"id":921524,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67945,"kind":"person","name":"Sommadossi Jean-Pierre","position":1,"cik":"0001296995","reported_name":"Sommadossi Jean-Pierre","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, and Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:46:07.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":99517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reflected one (1) share correction due to prior administrative rounding error with respect to RSU vesting in 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflected one (1) share correction due to prior administrative rounding error with respect to RSU vesting in 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":99517},"source":{"system":"sec-edgar","filing":"0001193125-26-036268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1296995/000119312526036268/ownership.xml","form_type":"4"}},{"id":921523,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67945,"kind":"person","name":"Sommadossi Jean-Pierre","position":1,"cik":"0001296995","reported_name":"Sommadossi Jean-Pierre","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, and Chairman"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:46:07.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":173466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant of 520,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The original grant of 520,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":173466},"source":{"system":"sec-edgar","filing":"0001193125-26-036268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1296995/000119312526036268/ownership.xml","form_type":"4"}},{"id":921522,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67945,"kind":"person","name":"Sommadossi Jean-Pierre","position":1,"cik":"0001296995","reported_name":"Sommadossi Jean-Pierre","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, and Chairman"}}],"security":"Common Stock","published_at":"2026-02-03T19:46:07.000Z","date":"2026-02-03","kind":"exercise","planned":false,"acquired":true,"shares":300000,"price":1.24,"value":372000.0,"ownership":{"direct":true},"balance_after":767830,"source":{"system":"sec-edgar","filing":"0001193125-26-036268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1296995/000119312526036268/ownership.xml","form_type":"4"}},{"id":921521,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67945,"kind":"person","name":"Sommadossi Jean-Pierre","position":1,"cik":"0001296995","reported_name":"Sommadossi Jean-Pierre","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, and Chairman"}}],"security":"Common Stock","published_at":"2026-02-03T19:46:07.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":106093,"price":4.24,"value":449834.32,"ownership":{"direct":true},"balance_after":467830,"source":{"system":"sec-edgar","filing":"0001193125-26-036268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296995/000119312526036268/ownership.xml","form_type":"4"}},{"id":921520,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67945,"kind":"person","name":"Sommadossi Jean-Pierre","position":1,"cik":"0001296995","reported_name":"Sommadossi Jean-Pierre","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, and Chairman"}}],"security":"Common Stock","published_at":"2026-02-03T19:46:07.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":272983,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":573923,"source":{"system":"sec-edgar","filing":"0001193125-26-036268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296995/000119312526036268/ownership.xml","form_type":"4"}},{"id":921951,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"grant","planned":false,"acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030."}],"balance_after":108000,"derivative":{"exercise_price":4.24,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":921950,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":921949,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The original grant of 100,000 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":921948,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":12132,"price":4.24,"value":51439.68,"ownership":{"direct":true},"balance_after":79329,"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":921947,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67961,"kind":"person","name":"Foster Wayne","position":1,"cik":"0001709769","reported_name":"Foster Wayne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-03T19:42:48.000Z","date":"2026-01-31","kind":"exercise","planned":false,"acquired":true,"shares":41333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":91461,"source":{"system":"sec-edgar","filing":"0001193125-26-036261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709769/000119312526036261/ownership.xml","form_type":"4"}},{"id":1102391,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:11.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were fully vested as of June 20, 2025"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were fully vested as of June 20, 2025"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089607/ownership.xml","form_type":"4"}},{"id":1102390,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:11.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-25-089607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089607/ownership.xml","form_type":"4"}},{"id":1102389,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:11.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089607/ownership.xml","form_type":"4"}},{"id":1102388,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35902,"kind":"person","name":"Murphy Polly A.","position":1,"cik":"0001829248","reported_name":"Murphy Polly A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:05:11.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":86045,"source":{"system":"sec-edgar","filing":"0000950170-25-089607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089607/ownership.xml","form_type":"4"}},{"id":1102576,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35951,"kind":"person","name":"DUNCAN BARBARA GAYLE","position":1,"cik":"0001353128","reported_name":"Duncan Barbara Gayle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1353128/000095017025089609/ownership.xml","form_type":"4"}},{"id":1102575,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35951,"kind":"person","name":"DUNCAN BARBARA GAYLE","position":1,"cik":"0001353128","reported_name":"Duncan Barbara Gayle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-25-089609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1353128/000095017025089609/ownership.xml","form_type":"4"}},{"id":1102574,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35951,"kind":"person","name":"DUNCAN BARBARA GAYLE","position":1,"cik":"0001353128","reported_name":"Duncan Barbara Gayle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1353128/000095017025089609/ownership.xml","form_type":"4"}},{"id":1102573,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35951,"kind":"person","name":"DUNCAN BARBARA GAYLE","position":1,"cik":"0001353128","reported_name":"Duncan Barbara Gayle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":62750,"source":{"system":"sec-edgar","filing":"0000950170-25-089609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1353128/000095017025089609/ownership.xml","form_type":"4"}},{"id":1102557,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025089606/ownership.xml","form_type":"4"}},{"id":1102556,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-25-089606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025089606/ownership.xml","form_type":"4"}},{"id":1102555,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089606","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025089606/ownership.xml","form_type":"4"}},{"id":1102554,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35943,"kind":"person","name":"BERGER FRANKLIN M","position":1,"cik":"0001273885","reported_name":"BERGER FRANKLIN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:05:09.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":506497,"source":{"system":"sec-edgar","filing":"0000950170-25-089606","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273885/000095017025089606/ownership.xml","form_type":"4"}},{"id":1102612,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:07.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017025089605/ownership.xml","form_type":"4"}},{"id":1102611,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:07.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-25-089605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017025089605/ownership.xml","form_type":"4"}},{"id":1102610,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:07.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017025089605/ownership.xml","form_type":"4"}},{"id":1102609,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35974,"kind":"person","name":"Polsky Bruce","position":1,"cik":"0001508458","reported_name":"Polsky Bruce","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:05:07.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":95206,"source":{"system":"sec-edgar","filing":"0000950170-25-089605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1508458/000095017025089605/ownership.xml","form_type":"4"}},{"id":1102751,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":36015,"kind":"person","name":"Adams Jerome M.","position":1,"cik":"0001863366","reported_name":"Adams Jerome M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:06.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089608","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863366/000095017025089608/ownership.xml","form_type":"4"}},{"id":1102750,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":36015,"kind":"person","name":"Adams Jerome M.","position":1,"cik":"0001863366","reported_name":"Adams Jerome M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:06.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-25-089608","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863366/000095017025089608/ownership.xml","form_type":"4"}},{"id":1102749,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":36015,"kind":"person","name":"Adams Jerome M.","position":1,"cik":"0001863366","reported_name":"Adams Jerome M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:06.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089608","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863366/000095017025089608/ownership.xml","form_type":"4"}},{"id":1102748,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":36015,"kind":"person","name":"Adams Jerome M.","position":1,"cik":"0001863366","reported_name":"Adams Jerome M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:05:06.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":62750,"source":{"system":"sec-edgar","filing":"0000950170-25-089608","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863366/000095017025089608/ownership.xml","form_type":"4"}},{"id":1102387,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35904,"kind":"person","name":"Lucidi Bruno","position":1,"cik":"0001829622","reported_name":"Lucidi Bruno","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vested in full on June 20, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089604/ownership.xml","form_type":"4"}},{"id":1102386,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35904,"kind":"person","name":"Lucidi Bruno","position":1,"cik":"0001829622","reported_name":"Lucidi Bruno","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:05.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":41200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date."}],"balance_after":41200,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":41200},"source":{"system":"sec-edgar","filing":"0000950170-25-089604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089604/ownership.xml","form_type":"4"}},{"id":1102385,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35904,"kind":"person","name":"Lucidi Bruno","position":1,"cik":"0001829622","reported_name":"Lucidi Bruno","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-24T22:05:05.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":29600,"derivative":{"underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000950170-25-089604","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089604/ownership.xml","form_type":"4"}},{"id":1102384,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35904,"kind":"person","name":"Lucidi Bruno","position":1,"cik":"0001829622","reported_name":"Lucidi Bruno","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T22:05:05.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":112750,"source":{"system":"sec-edgar","filing":"0000950170-25-089604","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089604/ownership.xml","form_type":"4"}},{"id":1102383,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":35903,"kind":"person","name":"Berman Howard","position":1,"cik":"0001952986","reported_name":"Berman Howard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T22:05:03.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":164800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in thirty-six (36) equal monthly installments following June 20, 2025 such that the option is fully vested on June 20, 2028."}],"balance_after":164800,"derivative":{"exercise_price":3.25,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":164800},"source":{"system":"sec-edgar","filing":"0000950170-25-089603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025089603/ownership.xml","form_type":"4"}},{"id":1249290,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":31472,"kind":"person","name":"KIRSCH ARTHUR S","position":1,"cik":"0001290976","reported_name":"Kirsch Arthur S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-24T23:52:21.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":164800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in thirty-six (36) equal monthly installments following February 20, 2025 such that the option is fully vested on February 20, 2028."}],"balance_after":164800,"derivative":{"exercise_price":3.14,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":164800},"source":{"system":"sec-edgar","filing":"0000950170-25-025901","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290976/000095017025025901/ownership.xml","form_type":"4"}},{"id":1283742,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2025 such that the option is fully vested on January 31, 2029."}],"balance_after":200000,"derivative":{"exercise_price":3.06,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283741,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":11250,"derivative":{"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283740,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":46800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."}],"balance_after":46800,"derivative":{"underlying":"Common Stock","underlying_shares":46800},"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283739,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14134,"price":3.06,"value":43250.04,"ownership":{"direct":true},"balance_after":81388,"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283738,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":11250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects shares received upon the satisfaction of performance criteria and time-vesting requirements associated with previously granted performance restricted stock units (\"PSUs\")."}],"balance_after":95522,"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283737,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67904,"kind":"person","name":"Hammond Janet MJ","position":1,"cik":"0001829899","reported_name":"Hammond Janet MJ","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:00:21.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":true,"shares":46800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,110 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan."}],"balance_after":84272,"source":{"system":"sec-edgar","filing":"0000950170-25-013853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013853/ownership.xml","form_type":"4"}},{"id":1283736,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T23:00:20.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":132800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2025 such that the option is fully vested on January 31, 2029."}],"balance_after":132800,"derivative":{"exercise_price":3.06,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":132800},"source":{"system":"sec-edgar","filing":"0000950170-25-013852","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013852/ownership.xml","form_type":"4"}},{"id":1283735,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T23:00:20.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects RSUs following the satisfaction of performance criteria of previously granted PSUs. The RSUs will vest on January 31, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":8750,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0000950170-25-013852","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013852/ownership.xml","form_type":"4"}},{"id":1283734,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-04T23:00:20.000Z","date":"2025-01-31","kind":"exercise","planned":false,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original grant of 100,000 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026."}],"balance_after":33333,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0000950170-25-013852","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013852/ownership.xml","form_type":"4"}},{"id":1283733,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:00:20.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":11517,"price":3.06,"value":35242.02,"ownership":{"direct":true},"balance_after":52081,"source":{"system":"sec-edgar","filing":"0000950170-25-013852","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013852/ownership.xml","form_type":"4"}},{"id":1283732,"issuer":{"id":5580,"kind":"organization","name":"Atea Pharmaceuticals, Inc."},"owners":[{"id":67905,"kind":"person","name":"Vavricka John","position":1,"cik":"0001829630","reported_name":"Vavricka John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-04T23:00:20.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":8750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects shares received upon the satisfaction of performance criteria and time-vesting requirements associated with previously granted performance restricted stock units (\"PSUs\")."}],"balance_after":63598,"source":{"system":"sec-edgar","filing":"0000950170-25-013852","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1593899/000095017025013852/ownership.xml","form_type":"4"}}],"next_cursor":"2025-02-04T23:00:20.000000Z,1283732"}